Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 3

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3Sarcoma 2Other hematologic neoplasm 2

Conditions

Leukemia, Myeloid, Acute 72Leukemia 68Precursor Cell Lymphoblastic Leukemia-Lymphoma 53Leukemia, Myelomonocytic, Acute 24Leukemia, Monocytic, Acute 22Leukemia, Erythroblastic, Acute 22Leukemia, Megakaryoblastic, Acute 20Congenital Abnormalities 18Myelodysplastic Syndromes 10Lymphoma 10Anemia, Refractory, with Excess of Blasts 10Burkitt Lymphoma 8Leukemia, Eosinophilic, Acute 7Leukemia, Myelomonocytic, Chronic 6Leukemia, Basophilic, Acute 6Myeloproliferative Disorders 5Leukemia, Biphenotypic, Acute 5Leukemia, Promyelocytic, Acute 4Dendritic Cell Sarcoma, Interdigitating 4Thrombocytopenia 3Neoplasm, Residual 3Myelodysplastic-Myeloproliferative Diseases 3Lymphoma, Non-Hodgkin 3Recurrence 2Philadelphia Chromosome 2Neutropenia 2Neoplasms 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2

Interventions

Rituximab 205Cyclophosphamide 178Peripheral Blood Stem Cell Transplantation 93Etoposide 91fludarabine phosphate 86Filgrastim 81Melphalan 62Vincristine 60Mycophenolic Acid 58Busulfan 58Whole-Body Irradiation 57Cytarabine 51Radiotherapy 49Doxorubicin 49Cyclosporine 49Tacrolimus 48Granulocyte Colony-Stimulating Factor 48Prednisone 46fludarabine 45Bendamustine Hydrochloride 45Methotrexate 44Carmustine 36Antilymphocyte Serum 34Dexamethasone 32Bortezomib 29Gemcitabine 27ibritumomab tiuxetan 25Methylprednisolone 23sargramostim 22Stem Cell Transplantation 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Lymphoma, Non-Hodgkin × Daunorubicin × Clear all
NCT00610883 2023-09-28

LSA4 Protocol for the Treatment of Advanced Pediatric and Adolescent Non-Hodgkins Lymphoma

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
17 enrolled 5 charts
Lymphoid

Lymphoma, Non-Hodgkin

NCT00002471 2013-06-20

Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
LymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

NCT00018954 2012-02-20

Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
LymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡